2883:TWSEKGI Financial Holding Co., Ltd. Analysis
Data as of 2026-06-20 - not real-time
¥1,960.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Dairei Co.,Ltd. is trading slightly below its 20‑day moving average and faces a bearish technical outlook, with the MACD line just crossing above its signal and the RSI hovering around the mid‑40s, suggesting limited upside momentum. Price action remains confined between a clear support around 1950 and resistance near 1987, while volume has been on a downtrend, indicating waning market interest. The stock’s current price of 1960 is far above the discounted cash‑flow fair value estimate of roughly 1127, flagging a substantial overvaluation gap. Fundamentally, the company posts a modest PE of 23.8 versus an industry average of 31.4, a low debt‑to‑equity ratio and strong cash reserves, but revenue is contracting and margins are thin.
The dividend yield of 3.06% is attractive, supported by a payout ratio near 73% and robust free cash flow, which helps cushion the valuation premium. However, the low ROE, negative revenue growth, and modest operating margins limit growth prospects, positioning Dairei more as a value play reliant on income generation than on capital appreciation.
The dividend yield of 3.06% is attractive, supported by a payout ratio near 73% and robust free cash flow, which helps cushion the valuation premium. However, the low ROE, negative revenue growth, and modest operating margins limit growth prospects, positioning Dairei more as a value play reliant on income generation than on capital appreciation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish technical trend with price below short‑term moving averages
- Decreasing volume indicating weakening buying pressure
- Significant overvaluation relative to DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Attractive dividend yield and strong cash position
- Low debt and stable balance sheet
- Continued revenue contraction limiting upside
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Fundamental overvaluation persists despite modest PE advantage
- Limited growth prospects and thin margins
- Stable sector fundamentals and low regulatory risk
Key Metrics & Analysis
Financial Health
Revenue Growth-1.60%
Profit Margin1.92%
P/E Ratio23.8
ROE5.47%
ROA3.65%
Debt/Equity0.11
P/B Ratio1.3
Op. Cash Flow¥309.0M
Free Cash Flow¥230.9M
Industry P/E31.4
Technical Analysis
TrendBearish
RSI41.0
Support¥1,950.00
Resistance¥1,987.00
MA 20¥1,972.05
MA 50¥1,979.72
MA 200¥1,981.94
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value¥1,127.42
GradeOvervalued
TypeValue
Dividend Yield3.06%
Risk Assessment
Beta-0.02
Volatility5.88%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.